INTRODUCTION AND OBJECTIVES: Inflammation amplifier (IA), a local chemokine inducer in non-immune cells is induced by the simultaneous activation of NF?B and STATs TNFa, and leads to a synergistic production of chemokines, growth factors, and cytokines. IA was essential for the development of inflammation in various autoimmune disease models. More recently, IA was critical for the development of chronic rejections both in murine models and human allogeneic lung transplantations (J Immunol. 189, 1928 and Int. Immunol. 25, 319) . The status of IA can be a new biomarker and its regulator can be a new therapeutic target in rejected kidney allografts (KA). The objective of this study was to investigate the contribution of IA during the rejection process in KA and to identify genes regulating IA.
METHODS: Primary human kidney cells (PHKC) were stimulated with IL-17, IL-6, TNFa, and expressions of chemokines and IL-6 were measured by RT-PCR. Among the genes highly expressed in PHKC with IA activation, we focused on a gene named Renal NFkB Enhancer-1 (RNE1). A deficiency of RNE1 suppressed chemokines and IL-6 after IA activation in PHKC, indicating that RNE1 might be a positive regulator in IA. In another experiment, urinary RNE1 in kidney transplant recipients (KTR) were measured by ELISA and clinical data (serum creatinine, CRP, urinary protein, urinary albumin, urinary NAG, and eGFR) were also compared among the KTR patient groups with normal histology, interstitial fibrosis and tubular atrophy (IF/TA), or chronic active antibody-mediated rejection (CAAMR).
RESULTS: PHKC expressed excess amounts of chemokines and IL-6 after IA activation by IL-17, IL-6, and TNFa. Urinary RNE1 in KTR showed significantly higher amount in CAAMR patients (48606 ng/ mgCre, n¼9) compared to IF/TA (10744 ng/mgCre, n¼21) and normal (6081 ng/mgCre, n¼13). In contrast, serum creatinine, CRP, eGFR, U-NAG levels showed no significant difference among patient groups.
CONCLUSIONS: IA was activated in PHKC, and urinary RNE1 was elevated in rejected KA. These results suggested that activation of IA is involved in KA rejection, and RNE1 could be a new biomarker. Now, we are planning to examine detailed molecular mechanisms how RNE1 regulates NF-kB pathway in kidney cells and to examine if it will be a new therapeutic target for allogeneic kidney transplantations.
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MP06-11 INCIDENTAL NEPHROLITHIASIS IN LIVE RELATED KIDNEY DONORS: EPIDEMIOLOGY, LONG TERM OUTCOME OF DONOR AND RECIPIENT.
Sanjoy Sureka*, Aneesh Srivastava, Uday Singh, Rakesh Kapoor, M S Ansari, Sandeep Kumar, Lucknow, India INTRODUCTION AND OBJECTIVES: The use of computerized tomography angiography for donor evaluation has resulted in the increased detection of incidental nephrolithiasis in living renal donor candidates. This study aims at reporting the epidemiology of asymptomatic renal stones in healthy live related potential donors as well as the management strategy and long-term outcome of kidney recipients with asymptomatic stones in donors.
METHODS: 2200 potential donors, between 2000 and 2015 were evaluated for the presence of asymptomatic renal stones. They were subjected to abbreviated metabolic panel for stone disease along with a detailed clinical history. Donors with stones > 15 mm, significant metabolic abnormalities and presence of associated risk factors for recurrent stone disease were rejected. Finally, 36 donors with stones, proceeded for donation with stone size of 2-15 mm (group I: stone ¼ 4 mm, n¼17; Group II: stone 5-15 mm, n¼19). Patients of group I were accepted for donation with stones in situ whereas, patients of group II were treated for stones prior to donation. Records were analyzed for recipient outcome, with special attention to stone events, as well outcome of donors in terms of stone recurrence in residual kidney.
RESULTS: Prevalence of asymptomatic renal stone in potential donors was 4.2 %. Mean age of the donor was 42.5AE10.5 years with mean GFR of the transplanted kidney being 38AE5.5 ml/min. In group I, follow up imaging revealed seven, four and one patients had residual stones (all ¼ 4 mm) at 1 month, 3 month and one year respectively. Similarly, in group II, five, three and one patient had residual stones (¼6 mm). Except one, none of the recipients had stone related events in post transplant period. One patient of group II required ureteroscopic stone retrieval in post transplant period. The mean serum creatinine of the recipients at 3 months and one year was (1AE0.25) mg/dl and (1.45AE0.4) mg/d respectivelyl. With a mean follow up of 6.5 years, donors did not show any stone recurrence in the residual kidney.
CONCLUSIONS: Transplantation of kidneys with small, asymptomatic renal stones in situ can be safely done with adequate post-operative follow up. Donors that donated the stone-bearing kidney fared equally well in terms of recurrence of stone in residual kidney.
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MP06-12 USEFULNESS OF MULTI-DETECTOR COMPUTED TOMOGRAPHY SCANNING FOR REPLACEMENT OF DIETHYLENETRIAMINE PENTAACETIC ACID (DTPA)
INTRODUCTION AND OBJECTIVES: Both estimated split renal function measured by DTPA renography and kidney volume measured by MDCT can be used to predict postoperative renal function in kidney donors. We compared predicted post donation eGFR which was estimated by split renal function and renal volume with measured eGFR.
METHODS: From January 2013 to May 2015, a total of 303 living kidney donors were analyzed. All donors underwent preoperative DTPA renography and MDCT scan. Bilateral renal cortex volume was measured by 3-dimension MDCT (Fig 1.) . We estimated DTPA-eGFR(Remained split renal function(%) x preoperative eGFR) and Vol-eGFR (remained renal volume/total renal volume (%) x preoperative eGFR) and analyzed with DTPA-eGFR, Vol-eGFR and MDRD eGFR(1 week, 1 month, 3 month, and 6 month postoperatively). Also, we compared DTPA-eGFR and Vol-eGFR with ?eGFR.
RESULTS: The mean value of DTPA-eGFR was 52.97AE10.32 (ml/minute/1.73 m2) and Vol-eGFR was 51.26AE10.26 (ml/minute/1.73 m2). Predicting dominating side was not agreed in 113/303 (37.3%). The MDRD eGFR showed a statistically significant correlation with total renal volume, DTPA-GFR and Vol-eGFR (p<0.001; Table1). ?eGFR shows significant correlation with total renal volume, DTPA-eGFR and Vol-eGFR(p<0.001). There were 101 patients who were eGFR less than 60ml/minute/1.73m2 at 6months after donor nephrectomy. Receiver operating characteristic (ROC) was performed to predict possibility of eGFR less than 60ml/minute/1.73m2 at six months with DTPA-eGFR and Vol-eGFR. DTPA-eGFR (AUC¼0.858 p<0.001), and Vol-eGFR (AUC¼0.878 p<0.001) could predict CKD III at 6 months (Figure1).
CONCLUSIONS: MDRD eGFR, Vol-eGFR, and DTPA-eGFR showed a statistically significant correlation. Moreover, Vol-eGFR and DTPA-eGFR were observed high prediction ability for CKD III at six months. In conclusion, Vol-eGFR was good predictive value for renal function recovery, and thus MDCT might substitute for DTPA renography in planning donor nephrectomy.
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MP06-13 BENEFICAL EFFECT OF HYDROGEN SULFIDE ON RENAL ISCHEMIA-REPERFUSION INJURY IN CLAWN MINIATURE SWINE
Yuichi Ariyoshi*, Mitsuhiro Sekijima, Takahiro Murokawa, Hisashi Sahara, Kagoshima, Japan; Motoo Araki, Yasutomo Nasu, Okayama, Japan; Kazuhiko Yamada, Kagoshima, Japan
INTRODUCTION AND OBJECTIVES:
The organ shortage is the major problem in kidney transplantation. To overcome this obstacle, kidney transplants of the marginal donor, cardiac death (DCD) and extended-criteria donors, were increasing. In this setting, the prevention of ischemia-reperfusion injury (IRI) is important for both early and longterm allograft function. Hydrogen Sulfides (H2S) have recently been reported to demonstrate both anti-inflammatory and cytoprotective effects. However, the efficacy and safety of H2S has yet to be elicited in a large animal model. We investigated whether H2S administration was effective for control of renal IRI and optimal administration method in a large animal model. METHODS: Female, MHC-inbred, CLAWN miniature swine (n¼8) underwent renal ischemia for 120-minutes by occlusion of the left renal artery and vein. Group 1 animals (n¼3) underwent renal ischemia exclusively without any additional treatment. Group 2 recipients (n¼2) received 1.1 mg/kg of intravenous Na2S 10-minutes prior to kidney reperfusion, followed by an additional 1.1 mg/kg of Na2S 30-minutes post-reperfusion. Group 3 recipients (n¼3) underwent selective renal artery administration of 1.1 mg/kg of Na2S 10-minutes prior to reperfusion, followed by an additional 1.1 mg/kg of Na2S 30-minutes post-reperfusion via the supra-renal aorta with concomitant occlusion of the infra-renal aorta, thus allowing for exclusive renal administration. Post-operative renal function was monitored by daily serum creatinine, analysis of circulating cytokine activity (TNF-a, IL-6 and HMGB1) to measure the inflammatory response to IRI and histological evaluation of renal biopsies obtained on post-operative days (POD) 2, 7 and 14.
RESULTS: H2S administration did not result in any adverse side effects in the recipients. All animals experienced transient acute kidney injury, achieving a peak serum creatinine level by POD 3. Recipients in the untreated group had the higher post-operative serum creatinine level than selective renal H2S administration group (POD4: 4.4 vs 8.6 mg/dl, p<0.001). Pathologically, Control group still showed strongly epithelial flattering and vacuolations, congestion of PTC, and condensed tubular nuclei as a result of influence of IRI. In systemic group, the structures of renal tubule were well preserved comparatively, and those changes in selective group were obviously disappeared. Furthermore, on POD 7, specimens from selective
